ABSOLUTE PRO VASCULAR SELF-EXPANDING STENT SYSTEM

Stent, Iliac

FDA Premarket Approval P110028

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the absolute pro vascular self-expanding stent system. The device is indicated for improving luminal diameter in patients with de novo or restenotic atherosclerotic lesions in the native common iliac artery and native external iliac artery with reference vessel diameters between 4. 3 mm and 9. 1 mm and lesions lengths up to 90 mm.

DeviceABSOLUTE PRO VASCULAR SELF-EXPANDING STENT SYSTEM
Classification NameStent, Iliac
Generic NameStent, Iliac
ApplicantABBOTT VASCULAR INC.
Date Received2011-07-25
Decision Date2012-02-22
Notice Date2012-02-27
PMAP110028
SupplementS
Product CodeNIO
Docket Number12M-0181
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address ABBOTT VASCULAR INC. 3200 Lakeside Drive santa Clara, CA 92054
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P110028Original Filing
S023 2022-11-21 135 Review Track For 30-day Notice
S022 2021-09-20 30-day Notice
S021 2020-08-05 30-day Notice
S020 2019-07-05 30-day Notice
S019 2018-06-26 30-day Notice
S018 2017-03-21 30-day Notice
S017 2017-03-16 30-day Notice
S016 2015-04-07 135 Review Track For 30-day Notice
S015 2015-02-24 30-day Notice
S014 2015-01-14 30-day Notice
S013 2014-07-18 30-day Notice
S012 2014-05-07 135 Review Track For 30-day Notice
S011 2013-08-16 135 Review Track For 30-day Notice
S010 2013-08-14 30-day Notice
S009 2013-07-29 30-day Notice
S008 2013-05-31 30-day Notice
S007 2013-01-14 30-day Notice
S006 2012-12-19 30-day Notice
S005 2012-10-15 30-day Notice
S004 2012-06-13 30-day Notice
S003 2012-05-24 30-day Notice
S002 2012-05-21 30-day Notice
S001 2012-05-11 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.